Shivani Handa

8PUBLICATIONS
54CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Molecular medicineFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 02, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

|Feb 03, 2026
Clinical outcomes of older patients with NPM1-mutated or KMT2A-rearranged AML before menin inhibitors: a Beat AML report.

Joshua F Zeidner, Jayanshu Jain, Rina Li Welkie

|Jul 11, 2025
Thrombocytopenia in myelofibrosis is characterized by inflammatory megakaryocytes with reduced G6B expression.

Lilian Varricchio, Gohar Mosoyan, Sebastian Elghaity-Beckley

|Jan 31, 2024
Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights.

Shivani Handa, Kyle A Farina, Michelle Becker

|Dec 15, 2022
Obstetric and perioperative management of patients with factor XI deficiency: a retrospective observational study.

Shivani Handa, Michelle Sterpi, Guilherme Sacchi De Camargo Correia

|Aug 05, 2022
Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy.

Shivani Handa, Jeong-Ok Lee, Andriy Derkach

Pageof 2

Frequent Collaborators

2 joint publications

Yazan Madanat

2 joint publications

Elie Traer

2 joint publications

Joshua F Zeidner

2 joint publications

John O Mascarenhas